These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
423 related articles for article (PubMed ID: 31959982)
1. Genome-wide CRISPR-Cas9 screening reveals ubiquitous T cell cancer targeting via the monomorphic MHC class I-related protein MR1. Crowther MD; Dolton G; Legut M; Caillaud ME; Lloyd A; Attaf M; Galloway SAE; Rius C; Farrell CP; Szomolay B; Ager A; Parker AL; Fuller A; Donia M; McCluskey J; Rossjohn J; Svane IM; Phillips JD; Sewell AK Nat Immunol; 2020 Feb; 21(2):178-185. PubMed ID: 31959982 [TBL] [Abstract][Full Text] [Related]
2. Engineering of Isogenic Cells Deficient for MR1 with a CRISPR/Cas9 Lentiviral System: Tools To Study Microbial Antigen Processing and Presentation to Human MR1-Restricted T Cells. Laugel B; Lloyd A; Meermeier EW; Crowther MD; Connor TR; Dolton G; Miles JJ; Burrows SR; Gold MC; Lewinsohn DM; Sewell AK J Immunol; 2016 Aug; 197(3):971-82. PubMed ID: 27307560 [TBL] [Abstract][Full Text] [Related]
3. Targeting pediatric cancers via T-cell recognition of the monomorphic MHC class I-related protein MR1. Cornel AM; van der Sman L; van Dinter JT; Arrabito M; Dunnebach E; van Hoesel M; Kluiver TA; Lopes AP; Dautzenberg NMM; Dekker L; van Rijn JM; van den Beemt DAMH; Buhl JL; du Chatinier A; Barneh F; Lu Y; Lo Nigro L; Krippner-Heidenreich A; Sebestyén Z; Kuball J; Hulleman E; Drost J; van Heesch S; Heidenreich OT; Peng WC; Nierkens S J Immunother Cancer; 2024 Mar; 12(3):. PubMed ID: 38519054 [TBL] [Abstract][Full Text] [Related]
4. T cell receptor diversity, specificity and promiscuity of functionally heterogeneous human MR1-restricted T cells. Lepore M; Lewinsohn DA; Lewinsohn DM Mol Immunol; 2021 Feb; 130():64-68. PubMed ID: 33360378 [TBL] [Abstract][Full Text] [Related]
5. Diversity of T Cells Restricted by the MHC Class I-Related Molecule MR1 Facilitates Differential Antigen Recognition. Gherardin NA; Keller AN; Woolley RE; Le Nours J; Ritchie DS; Neeson PJ; Birkinshaw RW; Eckle SBG; Waddington JN; Liu L; Fairlie DP; Uldrich AP; Pellicci DG; McCluskey J; Godfrey DI; Rossjohn J Immunity; 2016 Jan; 44(1):32-45. PubMed ID: 26795251 [TBL] [Abstract][Full Text] [Related]
6. Mucosal-associated invariant T cell receptor recognition of small molecules presented by MR1. Awad W; Le Nours J; Kjer-Nielsen L; McCluskey J; Rossjohn J Immunol Cell Biol; 2018 Jul; 96(6):588-597. PubMed ID: 29393543 [TBL] [Abstract][Full Text] [Related]
7. MR1-restricted T cells: the new dawn of cancer immunotherapy. Wang Z; Wang M; Chen J; Zhang L; Zhang L; Yu L Biosci Rep; 2020 Nov; 40(11):. PubMed ID: 33185693 [TBL] [Abstract][Full Text] [Related]
8. Recognition of the antigen-presenting molecule MR1 by a Vδ3 Rice MT; von Borstel A; Chevour P; Awad W; Howson LJ; Littler DR; Gherardin NA; Le Nours J; Giles EM; Berry R; Godfrey DI; Davey MS; Rossjohn J; Gully BS Proc Natl Acad Sci U S A; 2021 Dec; 118(49):. PubMed ID: 34845016 [TBL] [Abstract][Full Text] [Related]
10. The Diverse Family of MR1-Restricted T Cells. Gherardin NA; McCluskey J; Rossjohn J; Godfrey DI J Immunol; 2018 Nov; 201(10):2862-2871. PubMed ID: 30397170 [TBL] [Abstract][Full Text] [Related]
13. MAIT, MR1, microbes and riboflavin: a paradigm for the co-evolution of invariant TCRs and restricting MHCI-like molecules? Mondot S; Boudinot P; Lantz O Immunogenetics; 2016 Aug; 68(8):537-48. PubMed ID: 27393664 [TBL] [Abstract][Full Text] [Related]
14. The molecular basis for Mucosal-Associated Invariant T cell recognition of MR1 proteins. López-Sagaseta J; Dulberger CL; Crooks JE; Parks CD; Luoma AM; McFedries A; Van Rhijn I; Saghatelian A; Adams EJ Proc Natl Acad Sci U S A; 2013 May; 110(19):E1771-8. PubMed ID: 23613577 [TBL] [Abstract][Full Text] [Related]